INSULIN USED AS A HORMONE RATHER THAN A DRUG Trademark

Trademark Overview

On Monday, September 12, 2022, a trademark application was filed for INSULIN USED AS A HORMONE RATHER THAN A DRUG with the United States Patent and Trademark Office. The USPTO has given the INSULIN USED AS A HORMONE RATHER THAN A DRUG trademark a serial number of 97587791. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, November 5, 2024. This trademark is owned by Well Cell Global LLC. The INSULIN USED AS A HORMONE RATHER THAN A DRUG trademark is filed in the Education & Entertainment Services category with the following description:

providing health training and teaching services; providing training and teaching services on medical modalities for improving insulin resistance; providing training and teaching services on medical modality for treating diabetes
insulin used as a hormone rather than a drug

General Information

Serial Number97587791
Word MarkINSULIN USED AS A HORMONE RATHER THAN A DRUG
Filing DateMonday, September 12, 2022
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, November 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesproviding health training and teaching services; providing training and teaching services on medical modalities for improving insulin resistance; providing training and teaching services on medical modality for treating diabetes

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateWednesday, September 28, 2022
Primary Code041
First Use Anywhere DateWednesday, June 5, 2024
First Use In Commerce DateWednesday, June 5, 2024

Trademark Owner History

Party NameWell Cell Global LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHouston, TX 77079

Trademark Events

Event DateEvent Description
Thursday, September 15, 2022NEW APPLICATION ENTERED
Wednesday, September 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 13, 2023ASSIGNED TO EXAMINER
Wednesday, April 19, 2023NON-FINAL ACTION WRITTEN
Wednesday, April 19, 2023NON-FINAL ACTION E-MAILED
Wednesday, April 19, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 10, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, July 10, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, September 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 29, 2024ASSIGNED TO LIE
Monday, January 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 20, 2024ASSIGNED TO EXAMINER
Monday, March 18, 2024FINAL REFUSAL WRITTEN
Monday, March 18, 2024FINAL REFUSAL E-MAILED
Monday, March 18, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, June 6, 2024TEAS AMENDMENT OF USE RECEIVED
Thursday, June 6, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, June 6, 2024AMENDMENT TO USE PROCESSING COMPLETE
Thursday, June 6, 2024USE AMENDMENT FILED
Wednesday, July 24, 2024USE AMENDMENT ACCEPTED
Wednesday, July 24, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 24, 2024NON-FINAL ACTION E-MAILED
Wednesday, July 24, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 16, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, October 16, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, November 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 5, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED

Related Keywords

than drug rather hormone used insulin providing teaching services training medical modality treating diabetes resistance modalities